Day

Time

Session Type

Sheraton Chicago Ballroom

5-7 pm

1.   Opening Session

8:30-9 am

2.  Closing the Door on HIV Entry

9-9:30 am

3.   Viral Reservoirs and Ongoing Virus Replication in Patients on HAART: Implications for Clinical Management

10 am-12:30 pm

4.   NeuroAIDS

5.   Antiretroviral Chemotherapy I

6.   Progress in AIDS Vaccine Development

2-4 pm

7.   Drug Transporters

8.   HIV Vaccine Development

9.   Co-Pathogens and Opportunistic Infections (slide session + state-of-the-art lecture on HCV Co-Infection

4:30-5:45 pm

29. Pharmacology of Antiretroviral Chemotherapeutic Agents

8:30-9 am

30. Molecular Trickery on the HIV-Host Cell Battlefield

9-9:30 am

31. Pathogenesis and Treatment of HIV Neuropathy

10 am-12:30 pm

32. Epidemiology and Infection Control

33. Immunology

34. Developments in Virology

2-4 pm

35. HIV Virion Morphogenesis and Release

37. Structured Treatment Interruption (slide session + state-of-the-art lecture)

36. Maternal-Fetal Transmission of HIV-1: Implications for Care of HIV-Affected Women and Children

56. HIV Pathogenesis

8:30-9 am

57. DC-SIGN on Dendritic Cells, Novel HIV Receptor, Related Molecules

9-9:30 am

58. Development of CCR5 Antagonists as a New Class of Anti-HIV Therapeutic

10 am-12:30 pm

59. HIV-1 Infection in Women/Pediatrics

60. Antiretroviral Chemotherapy II

61. Developments in Viral Entry and Tropism

2-4 pm

62. Viral Reservoirs

64. Metabolic Complications of HIV-1 Disease (slide session + discussion)

63. Update on Epidemiology and Prevention

4:30-6:30 pm

94. Primary Infection

8-10 am

95. Advances in Antiretroviral Chemotherapeutics

10 am-12:30 pm

96. Late Breakers